| Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2 S Afkhami, MR D’Agostino, A Zhang, HD Stacey, A Marzok, A Kang, ... Cell 185 (5), 896-915. e19, 2022 | 227 | 2022 |
| Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection A Zhang, HD Stacey, MR D’Agostino, Y Tugg, A Marzok, MS Miller Nature Reviews Immunology 23 (6), 381-396, 2023 | 93 | 2023 |
| Innate immune memory of tissue-resident macrophages and trained innate immunity: re-vamping vaccine concept and strategies Z Xing, S Afkhami, J Bavananthasivam, DK Fritz, MR D’Agostino, ... Journal of Leucocyte Biology 108 (3), 825-834, 2020 | 72 | 2020 |
| Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses A Banerjee, N El-Sayes, P Budylowski, RA Jacob, D Richard, H Maan, ... Iscience 24 (5), 102477, 2021 | 48 | 2021 |
| Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut–lung axis M Jeyanathan, M Vaseghi-Shanjani, S Afkhami, JA Grondin, A Kang, ... Nature Immunology 23 (12), 1687-1702, 2022 | 41 | 2022 |
| Mucosal-pull induction of lung-resident memory CD8 T cells in parenteral tb vaccine-primed hosts requires cognate antigens and CD4 T cells S Haddadi, M Vaseghi-Shanjani, Y Yao, S Afkhami, MR D'Agostino, ... Frontiers in immunology 10, 2075, 2019 | 37 | 2019 |
| Airway Macrophages Mediate Mucosal Vaccine–Induced Trained Innate Immunity against Mycobacterium tuberculosis in Early Stages of Infection MR D’Agostino, R Lai, S Afkhami, A Khera, Y Yao, M Vaseghi-Shanjani, ... The Journal of Immunology 205 (10), 2750-2762, 2020 | 32 | 2020 |
| Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes V Jeyananthan, S Afkhami, MR D'Agostino, A Zganiacz, X Feng, M Miller, ... Frontiers in Immunology, 2808, 2022 | 20 | 2022 |
| Robust Evaluation of Ultraviolet-C Sensitivity for SARS-CoV-2 and Surrogate Coronaviruses SJ Boegel, M Gabriel, M Sasges, B Petri, MR D’Agostino, A Zhang, ... Microbiology Spectrum 9 (2), e00537-21, 2021 | 20 | 2021 |
| A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge ZR Sia, X He, A Zhang, JC Ang, S Shao, A Seffouh, WC Huang, ... Proceedings of the National Academy of Sciences 118 (22), e2025759118, 2021 | 20 | 2021 |
| Advancing immunotherapeutic vaccine strategies against pulmonary tuberculosis S Afkhami, AD Villela, MR D’Agostino, M Jeyanathan, A Gillgrass, Z Xing Frontiers in Immunology 11, 557809, 2020 | 19 | 2020 |
| Single-Dose Mucosal Immunotherapy With Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound After Antibiotic Cessation S Afkhami, R Lai, MR D’agostino, M Vaseghi-Shanjani, A Zganiacz, Y Yao, ... The Journal of infectious diseases 220 (8), 1355-1366, 2019 | 16 | 2019 |
| Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo SP Toniolo, S Afkhami, MR D’Agostino, BD Lichty, ED Cranston, Z Xing, ... Scientific reports 10 (1), 13349, 2020 | 15 | 2020 |
| Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice S Afkhami, MR D’Agostino, M Vaseghi-Shanjani, M Lepard, JX Yang, ... npj Vaccines 8 (1), 25, 2023 | 11 | 2023 |
| Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogens R Rashu, M Ninkov, CM Wardell, JM Benoit, NI Wang, CE Meilleur, ... PLoS pathogens 19 (6), e1011485, 2023 | 7 | 2023 |
| Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions A Zhang, H Chaudhari, Y Agung, MR D’Agostino, JC Ang, Y Tugg, ... Cell Reports Medicine 3 (8), 2022 | 4 | 2022 |
| Protocol for isolation and characterization of lung tissue resident memory T cells and airway trained innate immunity after intranasal vaccination in mice MR D’Agostino, S Afkhami, A Kang, A Marzok, MS Miller, Z Xing STAR Protocols 3 (3), 101652, 2022 | 2 | 2022 |
| Single-dose respiratory mucosal delivery of next-generation viral-vectored COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2 S Afkhami, MR D’Agostino, A Zhang, HD Stacey, A Marzok, A Kang, ... bioRxiv, 2021.07. 16.452721, 2021 | 2 | 2021 |
| Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R. 1 Lineage Variants, Canada RA Jacob, A Zhang, HO Ajoge, MR D'Agostino, K Nirmalarajah, ... Emerging Infectious Diseases 29 (7), 1386, 2023 | 1 | 2023 |
| Broadly-neutralizing antibodies that bind to the influenza hemagglutinin stalk domain enhance the effectiveness of neuraminidase inhibitors via Fc-mediated effector functions A Zhang, H Chaudhari, Y Agung, MR D’Agostino, JC Ang, MS Miller bioRxiv, 2021.11. 17.468248, 2021 | | 2021 |
